Tianhai Electronics (001365.SZ) IPO price is 27.19 yuan per share, with subscription starting on May 7th.
Tianhai Electronics (001365.SZ) announced that the company and the sponsor (lead underwriter) have negotiated and determined the issuing price for this offering to be 27.19 yuan per share based on preliminary inquiry results. Investors are advised to subscribe online and offline at this price on May 7, 2026 (T day). The offline subscription period is from 9:30 to 15:00, and the online subscription period is from 9:15 to 11:30 and from 13:00 to 15:00.
Tianhai Electronics (001365.SZ) announced that the company and the sponsor (lead underwriter) have determined the issue price for this issuance to be 27.19 yuan per share based on preliminary inquiry results. Investors are advised to subscribe online and offline at this price on May 7, 2026 (T day), with offline subscription available from 9:30 to 15:00 and online subscription from 9:15 to 11:30, and 13:00 to 15:00.
It is reported that the diluted static price-earnings ratio based on the issue price of 27.19 yuan per share for the issuer for the year 2025, after deducting non-recurring gains and losses, is 23.40 times, lower than the average static price-earnings ratio of the same industry published by China Securities Index Co., Ltd. on April 29, 2026 (T-3 day), which is 28.97 times. It is also lower than the average static price-earnings ratio of comparable listed companies in the same industry for the year 2025, after deducting non-recurring gains and losses, which is 29.78 times.
Related Articles

After-hours surge! Super Micro Computer, Inc. (SMCI.US) releases "decompressed" financial report: Q3 profit margin significantly improved, Q4 performance guidance exceeds expectations.

ASCLETIS-B(01672) will showcase data from multiple projects at the 33rd European Obesity Congress (ECO 2026).

Sinocare Inc. (300298.SZ): Subsidiary product recall action for the TRUE METRIX series of blood glucose monitoring systems.
After-hours surge! Super Micro Computer, Inc. (SMCI.US) releases "decompressed" financial report: Q3 profit margin significantly improved, Q4 performance guidance exceeds expectations.

ASCLETIS-B(01672) will showcase data from multiple projects at the 33rd European Obesity Congress (ECO 2026).

Sinocare Inc. (300298.SZ): Subsidiary product recall action for the TRUE METRIX series of blood glucose monitoring systems.






